At the time of writing, Gritstone Bio Inc [GRTS] stock is trading at $0.71, up 0.79%. An important factor to consider is whether the stock is rising or falling in short-term value. The GRTS shares have lost -3.20% over the last week, with a monthly amount drifted -11.81%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Gritstone Bio Inc [NASDAQ: GRTS] stock has seen the most recent analyst activity on February 28, 2024, when JMP Securities initiated its Mkt Outperform rating and assigned the stock a price target of $4. On March 28, 2023, B. Riley Securities initiated with a Buy rating and assigned a price target of $8 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $6 on October 31, 2022. Goldman downgraded its rating to a Sell but $2 remained the price target by the analyst firm on August 22, 2022.
For the past year, the stock price of Gritstone Bio Inc fluctuated between $0.67 and $3.33. Currently, Wall Street analysts expect the stock to reach $4.67 within the next 12 months. Gritstone Bio Inc [NASDAQ: GRTS] shares were valued at $0.71 at the most recent close of the market. An investor can expect a potential return of 557.75% based on the average GRTS price forecast.
Analyzing the GRTS fundamentals
According to Gritstone Bio Inc [NASDAQ:GRTS], the company’s sales were 0.84M for trailing twelve months, which represents an -90.96% plunge. Gross Profit Margin for this corporation currently stands at -2.55% with Operating Profit Margin at -76.68%, Pretax Profit Margin comes in at -70.92%, and Net Profit Margin reading is -70.92%. To continue investigating profitability, this company’s Return on Assets is posted at -1.06, Equity is -2.32 and Total Capital is -1.41. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.38.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6805 points at the first support level, and at 0.6555 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7300, and for the 2nd resistance point, it is at 0.7545.
Ratios To Look Out For
It is important to note that Gritstone Bio Inc [NASDAQ:GRTS] has a current ratio of 1.99. On the other hand, the Quick Ratio is 1.99, and the Cash Ratio is 1.69. Considering the valuation of this stock, the price to sales ratio is 91.19, the price to book ratio is 4.96.
Transactions by insiders
Recent insider trading involved Allen Andrew R, PRESIDENT AND CEO, that happened on May 16 ’24 when 24263.0 shares were sold. EVP, CHIEF OPERATING OFFICER, Jones Erin completed a deal on May 16 ’24 to sell 13749.0 shares. Meanwhile, Jooss Karin sold 13749.0 shares on May 16 ’24.
